Page 258 - Read Online
P. 258

Page 4 of 10                                                 Idhrees et al. Vessel Plus 2020;4:23  I  http://dx.doi.org/10.20517/2574-1209.2020.15

               Table 2. Merits and limitations of different imaging modalities to assess Takayasu arteritis
                                                     Merits                            Limitations
                Conventional digital   Evaluation of severity of stenotic lesions  Invasive
                subtraction angiography   Assment of central blood pressure  Risk of contrast induced nephropathy
                                    Concomitant therapeutic intervention as necessary  Radiation
                                                                            Inablity to assess the thickness of arterial
                                                                            wall
                CT angiography      Ability to evaluate stenotic and aneurysmal lesions    Risk of contrast induced nephropathy
                                    Ability to measure arterial wall thickness  Radiation
                                    When used in patients at high suspicion for TA, CTA has a
                                    sensitivity of 95% and specificity of 100%, using catheter-
                                    based angiography as the gold standard
                Magnetic resonance imaging Ability to evaluate stenotic and aneurysmal lesions Vessel  Decreased sensitivity for smaller branch
                                    wall evaluation (thickening, oedema, degeneration)   involvement
                                    Better assement of soft tissue when comapred to CTA No  Overestimate degrees of severe stenosis or
                                    radiation exposureSensitivity and specificity of 100% vs   occlusion
                                    catheter-based angiography
                18F-fluorodeoxyglucose   Localise active inflammation and intensity of inflammation   Not an angiographic study modality
                positron emission   Sensitivity and specificity 70.1% and 77.2%for evaluation
                tomography (FDG-PET)  of disease activity
                Duplex ultrasound   Ability to evaluate localised areas of stenosis and   Unable to provide a “roadmap” of vascular
                                    aneurysm                                lesions
                                    Non-invasive                            Unable to perform complete imaging of the
                                    No radiation exposure                   aortic arch and descending aorta
                                    Nocontrast                              Operator dependent
                Ansthoracic and     Non-invasive                            Unable to provide a ‘roadmap’ of vascular
                transesophageal     Ability for concomitant assessment of aortic root and   lesions
                echocardiography    aortic valve for insufficiency          Unable to differentiate among pathologies
                                    Can be used for surveillance of ascending aorta dilatation,  causing hypo echoic aortic wall mural
                                    detection of PHT, and possibly aortic wall thickening  thickening
                                                                            Operator dependent
               CT: computed tomography; CTA: CT angiography; TA: Takayasu’s arteritis; PHT: pulmonary hypertension

                                                                                [10]
               and has the potential to assess disease activity and response to treatment . FDG-PET is an operator-
               independent, non-invasive metabolic imaging tool helpful in diagnosis of TA. It has a high sensitivity and
               specificity, which increases the overall efficacy of the modality in diagnosis.

               General consideration in surgery
               The disease goes through three phases - pre-pulseless, pulseless and burnt out. This may be an
               oversimplification of the complex disease process, and not all patients follow this outline. The few general
               principles that physicians should keep in mind when treating such patients are as follows [20-23] : (1) usually an
               emergency surgery is not required as the stenotic lesions are well collateralized; (2) it is preferred to avoid
               surgery during the active phase. If required, suppress the active disease with medication before considering
               surgery; (3) TA patients are often on steroid therapy, making them high-risk surgical candidates due
               to effects of medications - for obesity, immunosuppression, bleeding diathesis; and (4) the disease is
               progressive, and hence, the patient should be on constant surveillance with medication. It is not uncommon
               to see complications such as restenosis, graft occlusion, graft site aneurysm and pseudoaneurysm due to
               the progressive nature of the disease.


               The incidence of all the disease is shown in Table 3 [6,24,25] .

               CORONARY ARTERY DISEASE
               Coronary artery disease (CAD) in TA was first described by Frovig and Loken in 1951, and Coronary artery
               bypass grafting (CABG) was first performed by Young and colleagues in 1973. Coronary angiographic and
                                                                                          [21]
               pathologic studies together have revealed coronary artery lesions in 9 to 11% of cases . CAD in TA is
               usually associated with lesions of peripheral branch arteries, and isolated CAD is present in less than 5% of
               patients [26-28] .
   253   254   255   256   257   258   259   260   261   262   263